Hospital News
Return to Liver Cancer Overview
More on Liver Cancer
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Children's Hospital Appoints Foremost Authority on Treatment of Pediatric Liver and Bowel Disease
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma
- Dr. Timothy Wang Named Chief of Gastroenterology at NewYork-Presbyterian/Columbia and Silberberg Professor of Medicine at Columbia University College of Physicians and Surgeons
- Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
- Largest U.S. Hepatitis C Trial Provides Insight Into Optimizing Treatment for Patients
- Liver Transplantation for Bile Duct Cancer Patients at NewYork-Presbyterian Hospital/Columbia University Medical Center
- New Comprehensive Gastrointestinal Health Center To Be Established at NewYork-Presbyterian Weill Cornell
- Scientists Identify Cells Necessary for Tumor Angiogenesis
- Two Novel Biologics Studied for Multiple Myeloma
Health Library
Clinical Services
Return to Liver Cancer Overview
More on Liver Cancer
- Advanced Diagnostics
- Bladder Cancer
- Blood Cancer
- Brain Cancer
- Center for Holistic Urology
- Center for Lymphoma and Myeloma
- Colon Cancer
- Early Lung Cancer Action Program
- Esophageal Cancer
- Gastroenterology and Hepatology (Digestive Diseases)
- Gastrointestinal Cancer
- Groundbreaking Therapeutics
- Gynecological Cancer
- Head and Neck Cancer
- Kidney Cancer
- Leukemia and Myeloproliferative Disease Center
- Liver Disease
- Lung Cancer
- Mesothelioma
- Minimal Access Surgery Center
- Oncology (Cancer)
- Pancreatic and Biliary Cancer
- Pediatric Cancer
- Prevention Programs
- Prostate Cancer
- Rectal Cancer
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Cancer
- Testicular Cancer
- Urologic Cancer
Liver Cancer
The NewYork-Presbyterian Cancer Centers' liver specialists provide high-level expertise in the treatment of liver tumors, with case volumes that are among the largest in the country. Joint activities between surgical oncologists and liver transplant specialists offer patients -- including those with liver metastases – streamlined care and potentially curative treatment options. These include a research protocol in which a radio-labeled monoclonal antibody is used to identify sites of metastatic disease.
Patients with liver cancer have access to the multidisciplinary programs of NewYork-Presbyterian Hospital/Columbia University Medical Center and NewYork-Presbyterian Hospital/Weill Cornell Medical Center which offer the latest advances in the diagnosis and treatment of liver cancer.
Therapeutic Excellence
Surgical Advances
Our surgeons are participating in a national clinical trial to evaluate the merit of combining a radio-frequency ablative technique that destroys tumor cells with intra-operative heated chemotherapy that is infused directly into the liver; the goal is to eliminate any microscopic disease that may remain after surgery. Further research endeavors focus on the use of gene vectors to deliver chemotherapy to hepatic metastases. Another clinical trial is investigating the effect of Cox 2 inhibitors on reducing the immunosuppression that occurs after surgery.
Radiation Oncology
Radiation oncologists have sophisticated treatment technology available, including intensity modulated radiation therapy (IMRT) and intraoperative brachytherapy, in which temporary or permanent radioactive sources are implanted at the time of surgery for unresectable liver tumors.
Interventional Radiology
The interventional radiology team performs direct ablation of liver tumors. Tiny needles are directed into the cancers under the guidance of computed tomography (CT), ultrasound, or fluoroscopic imaging. Radiofrequency ablation is then used to destroy the tumor. Alternatively, the physicians inject specific alcohol solutions or highly concentrated acetic acid to destroy tumors.
Research
Clinical Trials
Patients who come to the NewYork-Presbyterian Cancer Centers for care also have access to some of the most important and advanced clinical trials in the country for liver cancer. These trials include investigations related to:
- Ablative therapies for liver tumors and hepatic pumps for chemotherapy
- Use of a new drug to prevent immune system suppression following surgery
Research is also underway aimed at developing ways to use gene vectors to deliver chemotherapy to liver metastases.
Hospital News
Health Library
Clinical Services
RELATED LINKS
- Radiation Oncology, NewYork-Presbyterian/Columbia
- Radiation Oncology, NewYork-Presbyterian/Weill Cornell
- Digestive & Liver Diseases, NewYork-Presbyterian/Columbia
- Gastroenterology and Hepatology, NewYork-Presbyterian/Weill Cornell
- Hematology/Oncology, NewYork-Presbyterian/Columbia
- Hematology and Medical Oncology, NewYork-Presbyterian/Weill Cornell
- Herbert Irving Comprehensive Cancer Center
- Weill Cornell Comprehensive Cancer Care and Blood Disorders
